Search
BREAST CANCER VACCINE NOW IN CLINICAL TRIALS COULD SOMEDAY SAVE MILLIONS
Doctors said that although the vaccine is still in clinical trials, early results indicate that it seems to be working with few negative...
WARP DRIVE'S ODYSSEY ENDS WITH A BUYOUT-BY REVOLUTION, NOT SANOFI
Warp Drive Bio started up in 2012 with a potential buyer, Sanofi, already in place. Six years later the Cambridge, MA, company is being...
STUDY: REFLEXION HEALTH VIRTUAL THERAPY SYSTEM REDUCES REHAB COSTS
Reflexion Health, which has developed a “virtual physical therapy” system for patients recovering from surgery, said results from a...
APPLE WATCH USED FOR MAJOR CLINICAL STUDY OF KNEE AND JOINT REPLACEMENT PATIENTS
Apple Watch is thriving as an approachable health tracking solution, especially for heart-related issues thanks to heart rate alerts...
APPLE TEAMS UP WITH ZIMMER BIOMET FOR CLINICAL STUDY ON JOINT REPLACEMENT
Zimmer Biomet, a company that develops joint replacement products, today announced that it is working with Apple to improve patient...
ALNYLAM WON'T SEEK QUICK FDA NOD FOR SECOND RNAI DRUG
A few weeks ago, Alnylam Pharmaceuticals indicated it might seek a speedy FDA approval for what could be the second-ever RNA interference...
TRUE STORY: I GOT BOTOX TO HELP FIX MY POSTURE
About an hour before my first-ever Botox consultation at GoodSkin , the L.A. anti-aging clinic known for its "untouched" approach to...
SENIOR SCIENTIST, ANALYTICAL DEVELOPMENT - F1 ONCOLOGY - SAN DIEGO, CA
F1 Oncology is a clinical-stage biotechnology company committed to bringing to market CAR-T therapies for the treatment of cancer...From...
FDA LIFTS CLINICAL HOLD; GREEN-LIGHTS VERTEX AND CRISPR'S SICKLE CELL GENE THERAPY TRIAL
Posted on: 14 October 2018, The U.S. Food and Drug Administration has lifted a clinical hold and accepted an Investigational New Drug...
PERSONALIZED MEDICINE APPROACH FOR CHRONIC BLOOD CANCER PATIENTS
Eight different genetic subgroups of chronic blood cancer that link with patterns of clinical disease and patient prognosis identified....
NEW CLINICAL TRIALS SEEK TREATMENTS FOR CANINE CANCERS, MAY OFFER CLUES ON HUMAN CANCERS
Trials for osteosarcoma and solid tumors enrolling at Cummings Veterinary Medical Center at Tufts University for eligible canine candidates...
SCREENING FOR ATRIAL FIBRILLATION DURING AUTOMATIC BLOOD PRESSURE MEASUREMENTS
Andrew Lowe , Timothy H. Oh , Ralph Stewart Early Access Note: Early Access articles are new content made available in advance of the...
CHERYL LONDON APPOINTED TO NAMED PROFESSORSHIP
Cummings School researcher focuses on comparative oncology and improving cancer treatment in both pets and people Cheryl London, V90,...
EYEING NASH, GLYMPSE RAISES $22M TO TEST DISEASE DETECTION NANOTECH
Glympse Bio has developed sensor technology that it says can give clinicians an early look at a developing disease. As Glympse prepares...
PEOPLE LIKE GIVING PETS PUMPKIN, BUT IS IT GOOD FOR THEM?
Lisa Freeman, J86, V91, N96, head of the veterinary nutrition service at Cummings Veterinary Medical Center, fills us in I hear from...
CALL FOR HEALTH ENTREPRENEURS: EMBS BIOMEDICAL ENGINEERING ACCELERATOR PROGRAM
Engineer/Physician Team Track • Must be a team made up of at least one engineer and one physician • Can be in any clinical area with...
VIKING THERAPEUTICS ANNOUNCES DATA FROM IN VIVO STUDY OF VK2809 PRESENTED AT ORAL PLENARY SESSION OF THE 88TH ANNUAL MEETING OF AMERICAN THYROID ASSOCIATION
VK2809 Treatment Leads to Rapid Reduction in Steatosis, Inflammation and Liver Size in Mouse Model of Glycogen Storage Disease Type...
MENLO'S DRUG FAILS AGAIN IN CLINICAL TRIALS, THIS TIME FOR CHRONIC COUGH
A Menlo Therapeutics drug developed to treat chronic cough has failed to beat a placebo in a mid-stage study, and the clinical-stage...
PHYSICAL THERAPY MANAGEMENT OF CONGENITAL MUSCULAR TORTICOLLIS: A 2018 EVIDENCE-BASED CLINICAL PRACTICE GUIDELINE FROM THE APTA ACADEMY OF PEDIATRIC PHYSICAL THERAPY
Background: Congenital muscular torticollis is a postural deformity evident shortly after birth, typically characterized by lateral...
FDA OKS AKCEA RARE DISEASE DRUG, SETTING UP MARKET CLASH WITH ALNYLAM
For the second time since August, the FDA has approved a new treatment for a rare and deadly disease called hereditary transthyretin...